Metraipolis › archive › dc_f95bf1573a63
Albumin-Based Drug Delivery for Glioblastoma Treatment: Mechanistic Rationale, Preclinical Evidence, and Clinical Translation — Europe PMC PMID:42439657
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42439657
- DOI
- 10.3390/cells15131180
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T07:25:32.045Z
- SHA-256 of the archived text
49ef70ac1884c0dc64d47ce2775fb55980d0820a369b9e6669c35e9da5481648- Stable URL of this page
https://metraipolis.com/documento/dc_f95bf1573a63
How to cite
Albumin-Based Drug Delivery for Glioblastoma Treatment: Mechanistic Rationale, Preclinical Evidence, and Clinical Translation — Europe PMC PMID:42439657 — Europe PMC (en), https://europepmc.org/article/MED/42439657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f95bf1573a63 (Metraipolis archive dc_f95bf1573a63, sha256 49ef70ac1884c0dc64d47ce2775fb55980d0820a369b9e6669c35e9da5481648)
BibTeX
@misc{dcf95bf1573a63,
title = {Albumin-Based Drug Delivery for Glioblastoma Treatment: Mechanistic Rationale, Preclinical Evidence, and Clinical Translation — Europe PMC PMID:42439657},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42439657},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f95bf1573a63; sha256 49ef70ac1884c0dc64d47ce2775fb55980d0820a369b9e6669c35e9da5481648},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42439657. Agents can read the archived copy with the MCP tool read_document.